Vascular Embolization Market Size, Share, Trends And Analysis 2024 To 2033

The Business Research Company offers in-depth market insights through Vascular Embolization Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The vascular embolization market size has grown strongly in recent years. It will grow from $2.89 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prevalence of vascular diseases, rise in demand for non-coiling devices, surge in the use of clot agents, increased awareness about advanced treatment options.

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growth in the cases of chronic diseases, rising investments in r&d activities, growing preference for minimally invasive procedures, geographic expansion and access to healthcare, rising disposable incomes. Major trends in the forecast period include technological advancements, strategic collaborations, strategic collaborations, development of innovative vascular embolization devices.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12660&type=smp

Market Segmentation:
The vascular embolization market covered in this report is segmented -
1) By Product: Embolic Agents, Embolization Devices
2) By Embolization Technique: Coiling Devices, Non-Coiling Devices
3) By Application: Peripheral Vascular Diseases, Oncology, Urology, Neurology, Other Applications
4) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers

Major Driver - Vascular Disease Surge Fuels Anticipated Growth In The Vascular Embolization Market

The increasing prevalence of vascular diseases is expected to propel the growth of the vascular embolization market going forward. Vascular disease refers to a group of disorders that affect the blood vessels, including the arteries and veins, decrease blood flow, and lead to a variety of conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, peripheral artery diseases, and others. Vascular embolization is used for treating vascular disorders that involve occluding or obstructing blood vessels to stop bleeding, repair aneurysms, and improve blood supply in veins. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery diseases (PAD) reached 21 million in 2020, estimated to reach 23.8 million by 2030. Therefore, the increasing prevalence of vascular diseases is driving the growth of the vascular embolization market.

Competitive Landscape:
Major companies operating in the vascular embolization market report are Johnson and Johnson Co, Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Top Trend - Vascular Embolization Market Witnesses Growth With Technology Advancements

Technological advancements are a key trend gaining popularity in the vascular embolization market. Major companies operating in the vascular embolization market are developing new technologies to sustain their position in the market. For instance, in June 2022, India Medtronic Private Limited, a subsidy of Medtronic plc, a US-based medical device company, introduced Pipeline Vantage, a flex embolization device to treat brain aneurysms. Pipeline Vantage with shield technology is a revolutionary flow diverter with improved delivery design characteristics. These device characteristics make it easier and more reliable for clinicians to transport, deploy, and treat brain aneurysms and intracranial aneurysms while also providing a scaffold that encourages cell proliferation in the inner lining of the target blood vessel.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Vascular Embolization Market Characteristics
3. Vascular Embolization Market Trends And Strategies
4. Vascular Embolization Market - Macro Economic Scenario
5. Vascular Embolization Market Size And Growth
…..
27. Vascular Embolization Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.